Managing spasticity with drugs.
Eur J Phys Rehabil Med. 2010 Sep; 46(3):401-10.EJ

Abstract

Spasticity is a common symptom observed after pyramidal system lesion. The treatment of spasticity has considerably changed during last years, notably with the generalization of Botulinum toxin use. However, the treatment of spasticity should consider all therapeutic possibility in accordance with patient status and objective. Drugs are only a part of the treatment and physical therapy must always be used. Others treatments such as surgery, orthosis, occupational therapy must also be discussed individually. Several guidelines are now available for Botulinum toxin treatment but only the French guidelines consider all drug therapies. This review addresses the different drugs commonly used on the basis of an extensive review of literature. Some facts are clearly established by randomized controlled trials but a certain number of questions remains unclear and only clinical experience and consensus can guide injectors.

Links

Publisher Full Text

Authors+Show Affiliations

Simon O
Physical Medicine and Rehabilitation Department, AP-HP, GH Bichat, University Paris7, Paris, France. olivier.simon@bch.aphp.fr
Yelnik AP
No affiliation info available

MeSH

Administration, OralBaclofenBotulinum Toxins, Type AClonidineHumansInjections, SpinalMuscle Relaxants, CentralMuscle SpasticityNeuromuscular Agents

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20927006